Ouzaid, I <br/><br/>
[Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come].  [electronic resource] 

 -  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie  Jan 2013 
 - 1-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1166-7087 
<br/><br/><label>Standard No.: </label>10.1016/j.purol.2012.07.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstenes<br/>Androstenols--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzamides<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase III as Topic<br/>Denosumab<br/>Disease-Free Survival<br/>France--epidemiology<br/>Humans<br/>Male<br/>Nitriles<br/>Orchiectomy<br/>Phenylthiohydantoin--administration & dosage<br/>Prostatic Neoplasms--drug therapy<br/>Radioisotopes--administration & dosage<br/>Radium--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Survival Rate<br/>Taxoids--administration & dosage<br/>Tissue Extracts--administration & dosage<br/>Treatment Outcome